View in EDS HTML Full Text PDF Full Text

Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion.

Saved in:
Bibliographic Details
Title: Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion.
Authors: Chan EY; Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR. eugene.chan@cuhk.edu.hk.; Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR. eugene.chan@cuhk.edu.hk., Lin KY; Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR., Yap DY; Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR., Ma AL; Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR.
Source: Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2025 Mar; Vol. 40 (3), pp. 711-714. Date of Electronic Publication: 2024 Oct 28.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39466391
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chan+EY%22">Chan EY</searchLink>; Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR. eugene.chan@cuhk.edu.hk.; Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR. eugene.chan@cuhk.edu.hk.<br /><searchLink fieldCode="AU" term="%22Lin+KY%22">Lin KY</searchLink>; Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR.<br /><searchLink fieldCode="AU" term="%22Yap+DY%22">Yap DY</searchLink>; Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR.<br /><searchLink fieldCode="AU" term="%22Ma+AL%22">Ma AL</searchLink>; Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228708728%22">Pediatric nephrology (Berlin, Germany)</searchLink> [Pediatr Nephrol] 2025 Mar; Vol. 40 (3), pp. 711-714. <i>Date of Electronic Publication: </i>2024 Oct 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Case Reports
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International%22">Springer International </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8708728 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-198X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220931041X%22">0931041X </searchLink><i>NLM ISO Abbreviation: </i>Pediatr Nephrol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39466391
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00467-024-06570-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 711
    Titles:
      – TitleFull: Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chan EY
      – PersonEntity:
          Name:
            NameFull: Lin KY
      – PersonEntity:
          Name:
            NameFull: Yap DY
      – PersonEntity:
          Name:
            NameFull: Ma AL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2025 Mar
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1432-198X
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Pediatric nephrology (Berlin, Germany)
              Type: main
ResultId 1